A triple-receptor agonist peptide (GLP-1, GIP, and glucagon receptors), studied in metabolic research for its effects on energy expenditure, lipid handling, and weight-regulation pathways in preclinical models.
Detailed dosing options for GLP3-RT are being finalized and will be published on this page shortly. For laboratory research use only — not for human or veterinary use.
Certificate of Analysis Available
Independently verified by an accredited U.S. laboratory, on file by lot number.